iRadimed
IRMD
75 hedge funds and large institutions have $72M invested in iRadimed in 2015 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 20 increasing their positions, 16 reducing their positions, and 6 closing their positions.
467% more first-time investments, than exits
New positions opened: 34 | Existing positions closed: 6
130% more capital invested
Capital invested by funds: $31.3M → $72M (+$40.6M)
60% more funds holding
Funds holding: 47 → 75 (+28)
25% more repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 16
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JWA
JFS Wealth Advisors
Hermitage,
Pennsylvania
|
+$5.65M |
| 2 |
CM
Castleark Management
Chicago,
Illinois
|
+$4.95M |
| 3 |
CCA
Conestoga Capital Advisors
Wayne,
Pennsylvania
|
+$3.95M |
| 4 |
TCM
Tygh Capital Management
Portland,
Oregon
|
+$3.9M |
| 5 |
AIC
AWM Investment Company
New York
|
+$3.48M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BC
Broadfin Capital
New York
|
-$5.61M |
| 2 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
-$715K |
| 3 |
TC
TFS Capital
West Chester,
Pennsylvania
|
-$386K |
| 4 |
Stifel Financial
St. Louis,
Missouri
|
-$366K |
| 5 |
AI
Analytic Investors
Los Angeles,
California
|
-$341K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
TC
76
TFS Capital
West Chester,
Pennsylvania
| – | -$386K | -15,846 | Closed |
|
77
Goldman Sachs
New York
| – | -$226K | -9,263 | Closed |
|
78
Acadian Asset Management
Boston,
Massachusetts
| – | -$209K | -8,578 | Closed |
|
|
TRCT
79
Tower Research Capital (TRC)
New York
| – | -$53.7K | -1,900 | -100% |
|
80
Walleye Trading
New York
| – | -$7K | -300 | Closed |
|
81
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$4K | -158 | Closed |
|
IRMD Hedge Fund Activity: Q4 2015 in Review
75 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in iRadimed (IRMD) for Q4 2015, worth a combined $72M — up 130% from $31.3M a quarter earlier.
Buyers outnumbered sellers: 34 funds opened new IRMD positions and 6 closed out — a net gain of 28 holders — while 20 added to existing stakes and 16 trimmed.
The largest buyer was JFS Wealth Advisors, opening a new position worth an estimated $5.65M. The largest seller was Broadfin Capital, exiting entirely with an estimated $5.61M sold.
- 75 institutional investors held iRadimed (IRMD) as of Q4 2015, up from 47 in Q3 2015.
- Funds reported $72M of iRadimed stock for Q4 2015, up 130% quarter-over-quarter.
- 34 funds opened new iRadimed positions in Q4 2015 and 6 closed out, a net change of +28 holders.
- The largest iRadimed buyer in Q4 2015 was JFS Wealth Advisors, an estimated $5.65M added.
- The largest iRadimed seller in Q4 2015 was Broadfin Capital, an estimated $5.61M sold.
Based on aggregated 13F filings for Q4 2015.